VBI Vaccines Inc/BC Quarterly Other Assets, Current in USD from Q4 2015 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current assets classified as other.
Summary
VBI Vaccines Inc/BC quarterly Other Assets, Current history and growth rate from Q4 2015 to Q1 2024.
  • VBI Vaccines Inc/BC Other Assets, Current for the quarter ending March 31, 2024 was $1.99M, a 0.91% increase year-over-year.
Other Assets, Current, Quarterly (USD)
Other Assets, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.99M +$18K +0.91% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $1.76M -$4.3M -70.9% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 $3.87M -$138K -3.44% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $2.44M -$2.02M -45.3% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.98M -$2.71M -57.8% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 $6.06M +$2.43M +66.8% Dec 31, 2022 10-K 2024-04-16
Q3 2022 $4.01M -$973K -19.5% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $4.47M -$3.02M -40.3% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $4.68M -$3.89M -45.4% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $3.63M -$5.51M -60.3% Dec 31, 2021 10-K 2023-03-13
Q3 2021 $4.98M +$2.83M +131% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $7.49M +$7.01M +1454% Jun 30, 2021 10-Q 2021-08-02
Q1 2021 $8.58M +$8.32M +3174% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $9.14M +$8.69M +1932% Dec 31, 2020 10-K 2022-03-07
Q3 2020 $2.15M +$1.14M +112% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $482K -$55K -10.2% Jun 30, 2020 10-Q 2020-07-31
Q1 2020 $262K -$318K -54.8% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $450K -$62K -12.1% Dec 31, 2019 10-K 2021-03-02
Q3 2019 $1.02M -$1.45M -58.9% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $537K -$1.59M -74.7% Jun 30, 2019 10-Q 2019-08-09
Q1 2019 $580K -$357K -38.1% Mar 31, 2019 10-Q 2019-05-01
Q4 2018 $512K -$338K -39.8% Dec 31, 2018 10-K 2020-03-05
Q3 2018 $2.47M +$476K +23.9% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $2.12M +$42K +2.02% Jun 30, 2018 10-Q 2018-07-26
Q1 2018 $937K -$335K -26.3% Mar 31, 2018 10-Q 2018-05-01
Q4 2017 $850K +$300K +54.5% Dec 31, 2017 10-K 2019-02-25
Q3 2017 $1.99M Sep 30, 2017 10-Q 2017-11-13
Q2 2017 $2.08M Jun 30, 2017 10-Q 2017-07-31
Q1 2017 $1.27M Mar 31, 2017 10-Q 2017-05-15
Q4 2016 $550K -$87K -13.7% Dec 31, 2016 10-K 2018-02-26
Q4 2015 $637K Dec 31, 2015 10-K 2017-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.